CDC: STD rates skyrocketing in United States

The federal health agency said in a report released Tuesday that the numbers reflect a “steep sustained increase” in STDs since 2013

Rates of three STDs in US reach record high, CDC says

That year saw almost 2.3 million cases of chlamydia, gonorrhea, and syphilis, according to a new report from the Centers for Disease Control and Prevention. The emergence of antibiotic-resistant gonorrhea also deeply concerns officials, who fear a time when this STD no longer becomes treatable with current methods. Chlamydia was the worst offender with 1.7 million new cases, and about 45 percent of those to contract the STD were women between the ages of 15 and 24.

"M$3 ost cases go undiagnosed and untreated - which can lead to severe adverse health effects that include infertility, ectopic pregnancy, stillbirth in infants, and increased HIV risk", according to the CDC.

There's not enough screening for sexually transmitted diseases, particularly among young people who are most vulnerable, Harvey said.

Gonorrhea diagnoses increased 67 percent overall (from 333,004 to 555,608 cases according to preliminary 2017 data) and almost doubled among men (from 169,130 to 322,169).

Iranian lawmakers unimpressed by Rouhani's response to sanctions, economic woes
But parliament has summoned the president for the first time to answer questions on the crisis, and he is expected to appear on Tuesday.

"We expect gonorrhea will eventually wear down our last highly effective antibiotic, and additional treatment options are urgently needed", said Gail Bolan, M.D., director of CDC's Division of STD Prevention. To do that, we need the government to step up and ensure those working to prevent STDs have the resources they need to do so effectively. "There's ways to do effective programs based on evidence and data", Frazer said at the briefing.

"The explosion in STDs comes on the heels of years of cutbacks in federal funding", Harvey said. "If our representatives are serious about protecting American lives, they will provide adequate funding to address this crisis".

In 2015, the CDC began recommending that gonorrhea be treated with a single shot of ceftriaxone accompanied by an oral dose of azithromycin. However, 2017 saw the emergence of a "super gonorrhea" that is treatment resistant, and it's not inconceivable that the other diseases could evolve to resist antibiotics as well. Azithromycin was added to help delay the development of resistance to ceftriaxone.

Experts are anxious that azithromycin-resistant genes in some gonorrhea strains could cross over into gonorrhea that is not as susceptible to ceftriaxone.

Latest News